3549 results for «240»
3549 results
Essentials of lifetime management in patient undergoing TAVI using novel balloon expandable Myval Octacor THV
22 Sep 2023 – From AICT-AsiaPCR 2023
This session with a LIVE case provides information about the Octacor transcatheter heart valve technology, highlighting its procedural and clinical benefits. It also covers the Octalign technique, which ensures precise alignment of commissural and coronary access, and discusses the precise sizing, positioning, and deployment of Octacor THV.
Challenging STEMI cases
22 Sep 2023 – From AICT-AsiaPCR 2023
Dive into complex STEMI cases in this session, featuring presentations on unusual coronary anomalies, the challenges of long diffuse lesions, innovative approaches like intracoronary arterial retrograde thrombolysis, an intriguing case of acute coronary syndrome with uncommon causes, and much more!
Challenges in calcified lesions
21 Sep 2023 – From AICT-AsiaPCR 2023
Explore a variety of challenging cases in this session, from the perplexing uncrossable STEMI to the specialized "Blocked" balloon anchoring technique, the unique challenges of calcified lesions in elderly patients to the debulking of a calcified nodule within the left circumflex ostium through the stent strut,...
Three-year results of HOST-POLYTECH-ACS RCT comparing durable- vs. degradable-polymer DES
30 Aug 2023
Alex Sticchi provides his take on the 3-year results of HOST-POLYTECH-ACS RCT which were presented by Hyo-Soo Kim during the ESC 2023 congress in Amsterdam.
Author
Primary Outcomes of a Pivotal Multicenter Randomized Trial Comparing the AGENT Paclitaxel-Coated Ballon with Conventional Ballon Angioplasty for In-Stent Restenosis (AGENT IDE)
27 Oct 2023
Mirvat Alasnag provides her take on the AGENT IDE trial which was presented by Robert W. Yeh at TCT Congress 2023. This pivotal randomized trial compares the safety and efficacy of the AGENT DCB to conventional balloon angioplasty in patients with ISR. It is the first...
Author
CHOICE-CLOSURE: a randomized trial of plug-based versus suture-based large-bore vascular closure
06 Nov 2021
TCT 2021: Radoslaw Parma reviews the CHOICE-CLOSURE multicentre, randomized, controlled, open-label clinical trial presented by Mohamed Abdel-Wahab. The study compared outcomes of percutaneous femoral artery closure using a plug-based and a primary suture-based strategy in patients undergoing TAVI.
Author
INFINITY-SWEDEHEART - Percutaneous coronary intervention with a bioadaptor compared to a contemporary drug eluting stent- one year primary outcomes
03 Sep 2024
Daniele Giacoppo provides his take on the main results of the INFINITY-SWEDEHEART trial presented by David Erlinge at the ESC Congress 2024 in London.
Author
TRISCEND II trial: Randomized comparison of transcatheter valve replacement vs. optimal medical therapy for severe tricuspid regurgitation
04 Nov 2024
Alex Sticchi provides his take on the results of the TRISCEND II trial presented by Susheel K. Kodali and Suzanne V. Arnold at TCT 2024 in Washington.
Also watch the interview with Susheel K. Kodali
Author
Best of #AHA20 Interventional Trials
19 Nov 2020
Mirvat Al Asnag provides reviews and take-home messages from a selection of major Late-breaking Clinical Trials in Interventional Cardiology released at the 2020 virtual edition of the American Heart Association Congress.
Author
